Form D — Tempest Therapeutics, Inc.
0001193125-26-278048 · filed 2026-06-23
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $4,056,552
- Total sold
- $4,056,552
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Tempest Therapeutics, Inc.
- CIK
- 1544227
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 2000 SIERRA POINT PARKWAY, SUITE 400
BRISBANE, CA 94005 - Phone
- 415-798-8589
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Matthew Angel · Executive OfficerBrisbane, CA Find on LinkedIn ↗
-
Justin Trojanowski · Executive OfficerBrisbane, CA Find on LinkedIn ↗
-
John David Yee · DirectorBrisbane, CA Find on LinkedIn ↗
-
William Drake Richey · DirectorBrisbane, CA Find on LinkedIn ↗
View original on SEC EDGAR.